NDC 87063-299 – Flucelvax
Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL; Influenza A Virus A/tasmania/787/2025… · Injection, Suspension · Intramuscular
Product NDC87063-299
Product details
- Brand name
- Flucelvax
- Generic name
- INFLUENZA A VIRUS A/Tasmania/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Tasmania/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Arizona/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- Labeler
- ASCLEMED USA INC.
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125408
- Marketed since
- July 1, 2026
- Marketing end
- July 31, 2027
Active ingredients
- Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
- Influenza A Virus A/tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
- Influenza B Virus - B/arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 87063-299-10 | 10 SYRINGE, GLASS in 1 CARTON (87063-299-10) / .5 mL in 1 SYRINGE, GLASS (87063-299-01) | Jul 1, 2026 |
Other Flucelvax products
- 83703-088 Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell… · Injection, Suspension · Bamboo US BidCo LLC
- 70461-656 Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck… · Injection, Suspension · Seqirus Inc.
- 85766-263 Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck… · Injection, Suspension · Sportpharm LLC